Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) (350841)

From US Department of Health & Human Services: National Institutes of Health (NIH)

The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.

Type of Support

Overview

This grant program has established specific deadlines for standard grant applications, emphasizing the importance of timely submissions. It encourages applicants to submit Letters of Intent 30 days prior to the application due date as an optional but recommended step. The program outlines a structured timeline with deadlines on February 9 and July 15 for the years 2024 to 2026, ensuring applicants have clear, recurring dates to prepare their proposals. The mentioning of local time for submission deadlines suggests attention to the logistical needs of applicants from diverse geographical locations.

Eligibility

Organization's Location
duis Lorem, ea aliquip, adipisicing nulla, Lorem culpa, minim irure, culpa ipsum
Program Location
officia ea adipisicing ad non reprehenderit dolor cupidatat dolore mollit
Organization Type
up to 5.5M

Submission

Visit Apply for more information.

Similar grants